I agree that this site is using cookies. You can find further informations here.
X
Berdeja, Jesus G.
215  results:
Search for persons X
?
1

Patient perspectives on BCMA-targeted therapies for multipl..:

Hydren, Jay R. ; Lin, Dee ; Sweeney, Nathan W....
Frontiers in Health Services.  4 (2024)  - p. , 2024
Link: https://doi.org/10.3389/..
 
?
2

Carvykti (cilta-cel) Real World Outcomes across the Sarah C..:

Gregory, Tara ; Blunk, Betsy ; Cox, Ms. Tonya...
Transplantation and Cellular Therapy.  30 (2024)  2 - p. S385-S386 , 2024
Link: https://doi.org/10.1016/..
 
?
3

Ixazomib plus daratumumab and dexamethasone: Final analysis..:

Delimpasi, Sosana ; Dimopoulos, Meletios A. ; Straub, Jan...
American Journal of Hematology.  , 2024
Link: https://doi.org/10.1002/..
 
?
4

Biomarker Correlates of 3 Year Response in Cartitude-1: A P..:

Lin, Yi ; Usmani, Saad Z. ; Berdeja, Jesús G...
Transplantation and Cellular Therapy.  30 (2024)  2 - p. S377 , 2024
Link: https://doi.org/10.1016/..
 
?
5

MM-371 Pomalidomide, Daratumumab, and Dexamethasone After L..:

Bahlis, Nizar J. ; Samaras, Christy ; Reece, Donna...
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S494-S495 , 2023
Link: https://doi.org/10.1016/..
 
?
6

SOHO State-of-the-Art Updates and Next Questions | BCMA-Dir..:

Biltibo, Eden ; Berdeja, Jesus G.
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  5 - p. 310-321 , 2023
Link: https://doi.org/10.1016/..
 
?
7

Ciltacabtagene Autoleucel in Patients With Prior Allogeneic..:

Htut, Myo ; Dhakal, Binod ; Cohen, Adam D....
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  12 - p. 882-888 , 2023
Link: https://doi.org/10.1016/..
 
?
8

Time-Dependent Prognostic Value of Serological and Measurab..:

Paiva, Bruno ; Manrique, Irene ; Rytlewski, Julie...
Blood Cancer Discovery.  4 (2023)  5 - p. 365-373 , 2023
Link: https://doi.org/10.1158/..
 
?
9

POSTER: MDS-641 Randomized Phase 1-2 Study to Assess Safety..:

Garcia-Manero, Guillermo ; Bachiashvili, Kimo ; Griffiths, Elizabeth A....
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S187 , 2023
Link: https://doi.org/10.1016/..
 
?
10

Idecabtagene vicleucel for relapsed and refractory multiple..:

Lin, Yi ; Raje, Noopur S. ; Berdeja, Jesús G....
Nature Medicine.  29 (2023)  9 - p. 2286-2294 , 2023
Link: https://doi.org/10.1038/..
 
?
11

POSTER: MM-371 Pomalidomide, Daratumumab, and Dexamethasone..:

Bahlis, Nizar J. ; Samaras, Christy ; Reece, Donna...
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S225 , 2023
Link: https://doi.org/10.1016/..
 
?
12

Recommendations on prevention of infections during chimeric..:

Mohan, Meera ; Chakraborty, Rajshekhar ; Bal, Susan...
British Journal of Haematology.  203 (2023)  5 - p. 736-746 , 2023
Link: https://doi.org/10.1111/..
 
?
13

MDS-641 Randomized Phase 1-2 Study to Assess Safety and Eff..:

Garcia-Manero, Guillermo ; Bachiashvili, Kimo ; Griffiths, Elizabeth A....
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S376-S377 , 2023
Link: https://doi.org/10.1016/..
 
?
14

Rates of Influenza and Pneumococcal Vaccination and Correla..:

Thompson, Michael A. ; Boccadoro, Mario ; Leleu, Xavier...
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  3 - p. e171-e181 , 2023
Link: https://doi.org/10.1016/..
 
?
15

Plain language Summary of the CARTITUDE-1 Study of Ciltacab..:

Berdeja, Jesus G. ; Cohen, Adam D. ; Martin, Thomas...
Future Oncology.  19 (2023)  18 - p. 1235-1247 , 2023
Link: https://doi.org/10.2217/..
 
1-15